Biography 38: Scott William Lowe (1963 - )

Scott Lowe was born in Racine, Wisconsin. Although he was good at science and took most of the courses in high school, he never was very interested in science. He actually thought he would become a lawyer.

In 1982, Lowe started at the University of Wisconsin-Madison in chemical engineering. He thought that chemical engineering had something to do with chemicals and engineering (math). He quickly found out that it wasn't the field for him, and decided to take some general courses to figure out what he did want to do. Lowe really became interested in biology and molecular genetics through his undergraduate biochemistry and genetics courses. As an undergraduate project, he went to work in a research lab, and after graduation stayed in the lab for two more years as a technician.

In 1988, Lowe went to the Department of Biology at the Massachusetts Institute of Technology to start his graduate work. Coincidentally, Michael Hengartner started graduate school on the same day in the same department. Little did Lowe know at the time, but his interest in oncogenes would one day overlap with Hengartner's interest in cell death genes.

After his Ph.D., Lowe stayed at MIT for post-doctorate work and began studying the effects a known tumor suppressor, p53, on cell growth. He found that in radiation-damaged cells, p53 is needed for programmed cell death. Connecting programmed cell death with tumor cell growth gave new insight as to how cancer cells proliferate.

In 1994, Lowe was offered a research position at Cold Spring Harbor Laboratory (CSHL). He is currently a professor at the Watson School of Biological Sciences at CSHL. Lowe's lab continues to work on the p53 pathway and the effects cell death genes have on the growth, proliferation and repair of tumor cells.

Lowe spends most of his free time with his family, especially his two young children. He claims to be able to sing the introduction to "Thomas the Tank Engine" backwards and forwards. He also likes to hike and camp and skiing is his favorite sport.

Scott Lowe's research has shown how the regulation of the cell cycle affect cancer.

programmed cell death, p53 pathway, cold spring harbor laboratory, undergraduate biochemistry, tumor suppressor p53, death genes, scott lowe, tumor cell growth, william lowe, molecular genetics

  • ID: 16809
  • Source: DNALC.DNAFTB

Related Content

16802. Video 38: Scott Lowe, clip 2

The role of p53 in chemo- and radiotherapy given its role in programmed cell death.

  • ID: 16802
  • Source: DNAFTB

16805. Video 38: Scott Lowe, clip 5

How do the cell death proteins interact?

  • ID: 16805
  • Source: DNAFTB

16803. Video 38: Scott Lowe, clip 3

The importance of cell death in cancer.

  • ID: 16803
  • Source: DNAFTB

16801. Video 38: Scott Lowe, clip 1

How does p53, a tumor-suppressor gene, affect cell death?

  • ID: 16801
  • Source: DNAFTB

16804. Video 38: Scott Lowe, clip 4

Human homologue to C. elegans ced-4 gene.

  • ID: 16804
  • Source: DNAFTB

960. Causes, Smoking: p53

This series of animations shows how mutations in the p53 gene are found in 70% of lung tumors, the highest rate for any cancer.

  • ID: 960
  • Source: IC

16784. Animation 38: Development balances cell growth and death.

Leland Hartwell describes how cells regulate the timing of growth and cell division. Bob Horvitz and Mike Hengartner explain control mechanisms for cell death.

  • ID: 16784
  • Source: DNALC.DNAFTB

16793. Gallery 38: Scott Lowe (1)

How he ended up in Bob Horvitz's lab working on cell death.

  • ID: 16793
  • Source: DNAFTB

1009. Diagnosis, Pharmacogenetics

In this section pharmacogenetics is discussed and how people can have very different responses to the same drug and treatment.

  • ID: 1009
  • Source: IC

954. Causes, Smoking, all sections

This section explains that lung cancer is the leading cause of cancer deaths in the United States and it is almost entirely preventable, since the vast majority of cases are due to cigarette smoking.

  • ID: 954
  • Source: IC